$PETV
PetVivo Holdings, Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222031388 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $510.1K $223.3K $4.980K
YoY Change 900.21% 4383.53% 3.97%
Cost Of Revenue $223.7K $148.2K
YoY Change 125.95%
Gross Profit $286.4K $75.12K $4.980K
YoY Change -696.71% 1408.45% 12.16%
Gross Profit Margin 56.15% 33.64% 100.0%
Selling, General & Admin $2.357M $2.054M $992.0K
YoY Change 49.62% 107.1% 23.66%
% of Gross Profit 822.94% 2734.66% 19918.67%
Research & Development $248.2K $140.4K $116.4K
YoY Change 622.86% 20.63%
% of Gross Profit 86.64% 186.88% 2336.95%
Depreciation & Amortization $31.04K $28.72K $14.09K
YoY Change 100.48% 103.83% 59.03%
% of Gross Profit 10.84% 38.23% 282.93%
Operating Expenses $2.605M $2.195M $1.108M
YoY Change 61.85% 98.02%
Operating Profit -$2.319M -$2.120M -$1.103M
YoY Change 39.89% 92.1% -24950.23%
Interest Expense $7.200K $7.980K -$2.120K
YoY Change -53.61% -476.42% -99.6%
% of Operating Profit
Other Income/Expense, Net $7.200K $7.979K -$2.118K
YoY Change -53.61% -476.72%
Pretax Income -$2.312M -$2.112M -$1.105M
YoY Change 40.77% 91.01% -17.99%
Income Tax
% Of Pretax Income
Net Earnings -$2.312M -$2.112M -$1.105M
YoY Change 40.77% 91.01% -17.99%
Net Earnings / Revenue -453.16% -945.71% -22198.19%
Basic Earnings Per Share -$0.23 -$0.21 -$0.13
Diluted Earnings Per Share -$0.23 -$210.0K -$126.4K
COMMON SHARES
Basic Shares Outstanding 10.10M shares 10.04M shares 8.749M shares
Diluted Shares Outstanding 10.10M shares 10.05M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $374.5K $2.337M $8.817M
YoY Change -95.04% -73.49% 5172.35%
Cash & Equivalents $374.5K $2.337M $8.817M
Short-Term Investments
Other Short-Term Assets $479.7K $612.1K $618.8K
YoY Change 28.42% -1.08% 367.38%
Inventory $374.9K $305.0K $74.64K
Prepaid Expenses
Receivables $506.8K $129.1K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.736M $3.383M $9.511M
YoY Change -78.4% -64.43% 3050.35%
LONG-TERM ASSETS
Property, Plant & Equipment $520.3K $341.1K $352.0K
YoY Change 27.8% -3.1% 0.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.83K $12.83K $8.200K
YoY Change 0.0% 56.46% 0.0%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $832.4K $667.5K $403.2K
YoY Change 80.67% 65.55% -4.96%
TOTAL ASSETS
Total Short-Term Assets $1.736M $3.383M $9.511M
Total Long-Term Assets $832.4K $667.5K $403.2K
Total Assets $2.568M $4.051M $9.914M
YoY Change -69.77% -59.14% 1265.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $456.1K $422.1K $785.7K
YoY Change 73.23% -46.27% 4.56%
Accrued Expenses $1.042M $765.1K $419.8K
YoY Change 25.05% 82.27% 781.29%
Deferred Revenue
YoY Change
Short-Term Debt $6.840K $6.740K $6.360K
YoY Change 5.88% 5.97% -85.15%
Long-Term Debt Due $5.970K
YoY Change -98.79%
Total Short-Term Liabilities $1.565M $1.254M $1.218M
YoY Change 41.41% 2.96% -46.41%
LONG-TERM LIABILITIES
Long-Term Debt $22.16K $23.87K $30.44K
YoY Change -23.16% -21.58% -87.16%
Other Long-Term Liabilities $197.4K $209.8K $117.7K
YoY Change 77.99% 78.24% -18.56%
Total Long-Term Liabilities $219.6K $233.7K $148.1K
YoY Change 57.11% 57.72% -61.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.565M $1.254M $1.218M
Total Long-Term Liabilities $219.6K $233.7K $148.1K
Total Liabilities $1.784M $1.487M $1.366M
YoY Change 43.17% 8.9% -48.53%
SHAREHOLDERS EQUITY
Retained Earnings -$69.52M -$67.20M
YoY Change
Common Stock $10.11K $10.10K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $784.2K $2.563M $8.548M
YoY Change
Total Liabilities & Shareholders Equity $2.568M $4.051M $9.914M
YoY Change -69.77% -59.14% 1265.3%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.312M -$2.112M -$1.105M
YoY Change 40.77% 91.01% -17.99%
Depreciation, Depletion And Amortization $31.04K $28.72K $14.09K
YoY Change 100.48% 103.83% 59.03%
Cash From Operating Activities -$1.751M -$2.048M -$1.084M
YoY Change 19.47% 88.87% 357.54%
INVESTING ACTIVITIES
Capital Expenditures $210.3K -$58.67K -$30.15K
YoY Change -380.94% 94.59% -51.45%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$210.3K -$58.67K -$30.15K
YoY Change 180.94% 94.59% -51.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.610K 64.97K 9.789M
YoY Change -100.58% -99.34% 2811.08%
NET CHANGE
Cash From Operating Activities -1.751M -2.048M -1.084M
Cash From Investing Activities -210.3K -58.67K -30.15K
Cash From Financing Activities -1.610K 64.97K 9.789M
Net Change In Cash -1.963M -2.042M 8.674M
YoY Change 55.3% -123.54% 23230.77%
FREE CASH FLOW
Cash From Operating Activities -$1.751M -$2.048M -$1.084M
Capital Expenditures $210.3K -$58.67K -$30.15K
Free Cash Flow -$1.961M -$1.989M -$1.054M
YoY Change 41.03% 88.71% 502.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001512922
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2021Q2 PETV Stock Issued During Period Value Warrants Exercises
StockIssuedDuringPeriodValueWarrantsExercises
usd
CY2021Q3 PETV Stock Issued During Period Value Warrants Exercises
StockIssuedDuringPeriodValueWarrantsExercises
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
PETV Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
usd
PETV Increase Decrease In Interest Accrued On Convertible Notes Payable
IncreaseDecreaseInInterestAccruedOnConvertibleNotesPayable
usd
PETV Increase Decrease In Interest Accrued On Notes Payable Related Party
IncreaseDecreaseInInterestAccruedOnNotesPayableRelatedParty
usd
PETV Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
usd
PETV Repayments Of Paycheck Protection Program
RepaymentsOfPaycheckProtectionProgram
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
PETV Repayments Of Notes Payable Directors
RepaymentsOfNotesPayableDirectors
usd
PETV Stock Granted For Debt Conversion
StockGrantedForDebtConversion
usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
usd
CY2017Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P84M
CY2022Q3 PETV Base Rent Payments Included In Prepaid Expenses
BaseRentPaymentsIncludedInPrepaidExpenses
usd
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40715
dei Entity Registrant Name
EntityRegistrantName
PetVivo Holdings, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0363559
dei Entity Address Address Line1
EntityAddressAddressLine1
5251 Edina Industrial Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
Edina
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55439
dei City Area Code
CityAreaCode
(952)
dei Local Phone Number
LocalPhoneNumber
405-6216
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10095275 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2337093 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6106827 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
129142 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2596 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
304967 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
612128 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547664 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
3383330 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
6755400 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
341071 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311549 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
269592 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
299101 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43986 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48452 usd
CY2022Q3 us-gaap Security Deposit
SecurityDeposit
12830 usd
CY2022Q1 us-gaap Security Deposit
SecurityDeposit
12830 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
326408 usd
CY2022Q1 us-gaap Other Assets
OtherAssets
360383 usd
CY2022Q3 us-gaap Assets
Assets
4050809 usd
CY2022Q1 us-gaap Assets
Assets
7427332 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
422141 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
323384 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
765086 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784375 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59807 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59178 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6737 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6549 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1253771 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1173486 usd
CY2022Q3 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
23868 usd
CY2022Q1 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
27201 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
209785 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239923 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
233653 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
267124 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1487424 usd
CY2022Q1 us-gaap Liabilities
Liabilities
1440610 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10095275 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10095275 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9988361 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9988361 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
10095 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
9988 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69756728 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69103155 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67203438 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63126421 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2563385 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4050809 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7427332 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
223280 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4977 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
281454 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9122 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
148159 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
201179 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5051 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
75121 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
4977 usd
us-gaap Gross Profit
GrossProfit
80275 usd
us-gaap Gross Profit
GrossProfit
4071 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
867985 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
235767 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1524554 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
285498 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
140384 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
116380 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
212040 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
253317 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1186320 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
756186 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2429342 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1087131 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2194689 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1108333 usd
us-gaap Operating Expenses
OperatingExpenses
4165936 usd
us-gaap Operating Expenses
OperatingExpenses
1625946 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2119568 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4085661 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1103356 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1621875 usd
PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
31680 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7979 usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2118 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
8644 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5908 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7979 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2118 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8644 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
25772 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2111589 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1105474 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4077017 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1596103 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2111589 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1105474 usd
us-gaap Net Income Loss
NetIncomeLoss
-4077017 usd
us-gaap Net Income Loss
NetIncomeLoss
-1596103 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10053463 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8749233 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10021090 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7757099 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
231231 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4252525 usd
CY2022Q3 PETV Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
66558 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
49920 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
305971 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2111589 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2563385 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-896979 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
343098 usd
CY2021Q2 PETV Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
40000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
232658 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55674 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-490629 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-716178 usd
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4968531 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4889252 usd
CY2021Q3 PETV Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2031 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
210000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
104092 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
196000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-1105474 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
8548254 usd
us-gaap Net Income Loss
NetIncomeLoss
-4077017 usd
us-gaap Net Income Loss
NetIncomeLoss
-1596103 usd
us-gaap Share Based Compensation
ShareBasedCompensation
537202 usd
us-gaap Share Based Compensation
ShareBasedCompensation
159766 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
166114 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
58510 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27689 usd
PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
31680 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
180658 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
285238 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
126546 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
206654 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
74637 usd
PETV Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
-280163 usd
PETV Increase Decrease In Interest Accrued On Convertible Notes Payable
IncreaseDecreaseInInterestAccruedOnConvertibleNotesPayable
192 usd
PETV Increase Decrease In Interest Accrued On Notes Payable Related Party
IncreaseDecreaseInInterestAccruedOnNotesPayableRelatedParty
4013 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
79468 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
212506 usd
PETV Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-36808 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3749581 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1340137 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
83566 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17059 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19154 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83566 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36213 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10200881 usd
PETV Proceeds From Warrant Exercise
ProceedsFromWarrantExercise
66558 usd
PETV Proceeds From Warrant Exercise
ProceedsFromWarrantExercise
42031 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3145 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2728 usd
PETV Repayments Of Paycheck Protection Program
RepaymentsOfPaycheckProtectionProgram
1373 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
48267 usd
PETV Repayments Of Notes Payable Directors
RepaymentsOfNotesPayableDirectors
20300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63413 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10170244 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3769734 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8793894 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6106827 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23578 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2337093 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8817472 usd
us-gaap Interest Paid Net
InterestPaidNet
2022 usd
us-gaap Interest Paid Net
InterestPaidNet
8468 usd
PETV Stock Granted For Debt Conversion
StockGrantedForDebtConversion
232658 usd
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
196000 usd
us-gaap Stock Issued1
StockIssued1
49920 usd
us-gaap Stock Issued1
StockIssued1
210000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_z2zOz2MKYuag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(D)</i></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zCYDB8IWDMzf">Use of Estimates</span></i></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include collectability of accounts receivable, inventory obsolescence, estimated useful lives and potential impairment of property and equipment and intangibles, estimate of fair value of share-based payments, future rebates payable to a distributor, product refund liabilities, lease assets and liabilities and valuation of deferred tax assets.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_znksphFRMs42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(F)</i></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_zTXXr6sSyC2l">Concentration-Risk</span></i></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with various financial institutions, which at times may exceed federally insured limits. As of September 30, 2022 and March 31, 2022, the Company did have cash balances in excess of the federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
PETV Distribution Fee Payable Percentage
DistributionFeePayablePercentage
0.05 pure
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
124488 usd
CY2022Q3 PETV Distribution Fee Payable
DistributionFeePayable
6224 usd
CY2022Q3 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2022Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
304967 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
45479 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11889 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
21525 usd
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
22960 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
237963 usd
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
63464 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
304967 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
612128 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547664 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
599774 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
516208 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
258703 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
204659 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
341071 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311549 usd
CY2022Q3 us-gaap Depreciation
Depreciation
28719 usd
CY2021Q3 us-gaap Depreciation
Depreciation
11756 usd
us-gaap Depreciation
Depreciation
54044 usd
us-gaap Depreciation
Depreciation
23627 usd
CY2022Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2022Q3 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2022Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3852213 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3847747 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43986 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48452 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2240 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2333 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4466 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4062 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
432848 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
452137 usd
CY2022Q3 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2022Q1 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
765086 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784375 usd
CY2022Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06 pure
CY2022Q3 us-gaap Notes Payable
NotesPayable
30605 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
33750 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
6737 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23868 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
6549 usd
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27201 usd
CY2022Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
8183 usd
CY2021Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
14341 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 usd
CY2017Q2 us-gaap Area Of Land
AreaOfLand
3577 sqft
CY2017Q2 PETV Percentage Of Increase In Rent
PercentageOfIncreaseInRent
0.02 pure
CY2017Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
In January 2020, the Company entered into a lease amendment to extend the lease term through November of 2026
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2022Q3 PETV Base Rent
BaseRent
2205 usd
CY2022Q1 PETV Base Rent
BaseRent
2205 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
25541 usd
CY2021Q3 us-gaap Payments For Rent
PaymentsForRent
22892 usd
us-gaap Payments For Rent
PaymentsForRent
60976 usd
us-gaap Payments For Rent
PaymentsForRent
34403 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
29711 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
60588 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61964 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
63372 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
55103 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
270738 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1146 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
269592 usd
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the extended lease term to November 2026
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0028 pure
CY2022Q3 PETV Operating Lease Liability Gross
OperatingLeaseLiabilityGross
269592 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
269592 usd
CY2022Q3 PETV Operating Lease Rightofuse Current Asset
OperatingLeaseRightofuseCurrentAsset
269592 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
269592 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59807 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
209785 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
269592 usd
us-gaap Net Income Loss
NetIncomeLoss
-4077017 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3749581 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67203438 usd
CY2021Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
80522 shares
CY2021Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
230000 usd
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2658 usd
CY2021Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.732 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.078 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.050 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.105 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0296 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0369 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0147 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0214 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
195000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.56
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
195000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100200 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
198789 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.26
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
393789 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
68841 usd
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
43789 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
195000 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
350000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
43789 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.56
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.89
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.07
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
284475 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
104092 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
515706 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
159766 usd

Files In Submission

Name View Source Status
0001493152-22-031388-index-headers.html Edgar Link pending
0001493152-22-031388-index.html Edgar Link pending
0001493152-22-031388.txt Edgar Link pending
0001493152-22-031388-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
petv-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
petv-20220930_cal.xml Edgar Link unprocessable
petv-20220930_def.xml Edgar Link unprocessable
petv-20220930_lab.xml Edgar Link unprocessable
petv-20220930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending